Health9 hours ago
Novo Nordisk Gains U.S. Approval for Rybelsus to Combat Heart Disease
Novo Nordisk has secured approval from the U.S. Food and Drug Administration (FDA) to market its oral GLP-1 medication, Rybelsus, specifically aimed at reducing the risk...